Latest news with #drugregulation
Associated Press
02-06-2025
- Business
- Associated Press
Pharmacovigilance Aspects of Licensing Agreements Training Course: How to Remain Compliant with Legal Obligations and Satisfy Good Pharmacovigilance (ONLINE EVENT: July 1, 2025)
DUBLIN--(BUSINESS WIRE)--Jun 2, 2025-- The 'Pharmacovigilance Aspects of Licensing Agreements Training Course' training has been added to offering. This intensive one-day seminar will review the existing global requirements relating to pharmacovigilance in contractual agreements. The emphasis will be on practical advice as to how to remain compliant with the legal obligations and how to satisfy good pharmacovigilance practice and quality management requirements, as well as how to promote harmonious business partnerships. Whilst licensing agreements involving medicines are primarily driven by commercial factors, the successful handling of pharmacovigilance obligations is a critical, but frequently overlooked, consideration. Negotiating the safety arrangements to ensure regulatory compliance by both partners can be a complex process, which is further compounded by a lack of harmonisation and clarity of the regulations around the world. A practical workshop session will help consolidate the information provided under the guidance of our expert trainers. Who Should Attend: The programme will be of interest to all personnel involved in business development and licensing agreements, including those working in drug safety and pharmacovigilance, regulatory affairs and drug registration, medical directors, R&D directors and company lawyers. Benefits of attending Certifications: Key Topics Covered: Global regulatory framework Best pharmacovigilance practices in licensing agreements Legal aspects Audit and compliance aspects of third-party agreements Workshop - practical aspects of licensing agreement For more information about this training visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. View source version on CONTACT: Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 KEYWORD: INDUSTRY KEYWORD: PROFESSIONAL SERVICES EDUCATION HEALTH LEGAL PHARMACEUTICAL TRAINING SOURCE: Research and Markets Copyright Business Wire 2025. PUB: 06/02/2025 07:47 AM/DISC: 06/02/2025 07:45 AM
Bloomberg
21-05-2025
- Health
- Bloomberg
Danger May Lurk in a Popular Drug for a Common Condition
Hi, it's Anna in Virginia. Bloomberg just published an investigation I did on a drug you can easily buy in most stores like Walmart and Target that isn't FDA approved. But before I tell you more ... When you walk into a pharmacy or retailer with a health and wellness aisle, it would make sense that you'd assume any drug you pick up would have been thoroughly vetted by the Food and Drug Administration.
